Oncopharmpod
ICI + Bacterial Supplementation
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:12:24
- Mas informaciones
Informações:
Sinopsis
We take a peak at an intriguing study (n = 29) that gave some metastatic RCC patients receiving nivolumab + ipilimumab a supplement of a bacterium (n = 19) and a control group. We discuss what to look for in the future studies that are likely to follow with similar methods.
